Cathepsin H indirectly regulates morphogenetic protein-4 (BMP-4) in various human cell lines

Turk V, Turk B, Turk D. Lysosomal cysteine proteases: facts and opportunities. EMBO J 2001; 20: 4629-33.10.1093/emboj/20.17.4629Search in Google Scholar

Kirschke H. Cathepsin H. In: Barret AJ, Rawlings ND, Woessner JF. Handbook of proteolytic enzymes. 2nd edition. London: Elsevier Academic Press; 2004. p. 1089-92.Search in Google Scholar

Kirschke H, Barrett AJ, Rawlings ND. Lysosomal cysteine proteases. 2nd edition. Oxford: Oxford University Press; 1998.Search in Google Scholar

Ritonja A, Popovic T, Kotnik M, Machleidt W, Turk V. Amino acid sequences of the human kidney cathepsins H and L. FEBS Lett 1988; 228: 341-5.10.1016/0014-5793(88)80028-0Search in Google Scholar

Vasiljeva O, Dolinar M, Turk V, Turk B. Recombinant human cathepsin H lacking the mini chain is an endopeptidase. Biochemistry 2003; 42: 13522-8.10.1021/bi035355kSearch in Google Scholar

Nishimura Y, Kato K. Identification of latent procathepsin H in microsomal lumen: characterization of proteolytic processing and enzyme activation. Arch Biochem Biophys 1988; 260: 712-8.10.1016/0003-9861(88)90500-0Search in Google Scholar

Kominami E, Tsukahara T, Hara K, Katunuma N. Biosyntheses and processing of lysosomal cysteine proteinases in rat macrophages. FEBS Lett 1988; 231: 225-8.10.1016/0014-5793(88)80736-1Search in Google Scholar

Gocheva V, Chen X, Peters C, Reinheckel T, Joyce JA. Deletion of cathepsin H perturbs angiogenic switching, vascularization and growth of tumors in a mouse model of pancreatic islet cell cancer. Biol Chem 2010; 391: 937-45.10.1515/bc.2010.080Search in Google Scholar

Wu SM, Huang YH, Yeh CT, Tsai MM, Liao CH, Cheng WL, et al. Cathepsin H regulated by the thyroid hormone receptors associate with tumor invasion in human hepatoma cells. Oncogene 2011; 30: 2057-69.10.1038/onc.2010.58521217776Search in Google Scholar

Ciric E, Sersa G. Radiotherapy in combination with vascular-targeted therapies. Radiol Oncol 2010; 44: 67-78.10.2478/v10019-010-0025-9342368422933894Search in Google Scholar

Gabrijelcic D, Svetic B, Spaic D, Skrk J, Budihna M, Dolenc I, et al. Cathepsins B, H and L in human breast carcinoma. Eur J Clin Chem Clin Biochem 1992; 30: 69-74.Search in Google Scholar

Schweiger A, Christensen IJ, Nielsen HJ, Sørensen S, Brünner N, Kos J. Serum cathepsin H as a potential prognostic marker in patients with colorectal cancer. Int J Biol Markers 2004; 19: 289-94.10.1177/172460080401900406Search in Google Scholar

Kos J, Stabuc B, Schweiger A, Krasovec M, Cimerman N, Kopitar-Jerala N, et al. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. Clin Cancer Res 1997; 3: 1815-22.Search in Google Scholar

Budihna M, Strojan P, Smid L, Skrk J, Vrhovec I, Zupevc A, et al. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma. Biol Chem Hoppe Seyler 1996; 377: 385-90.10.1515/bchm3.1996.377.6.3858839984Search in Google Scholar

Strojan P. Cysteine cathepsins and stefins in head and neck cancer: an update of clinical studies. Radiol Oncol 2008; 42: 69-81.10.2478/v10019-008-0006-4Search in Google Scholar

Sivaparvathi M, Sawaya R, Gokaslan ZL, Chintala SK, Rao JS. Expression and the role of cathepsin H in human glioma progression and invasion. Cancer Lett 1996; 104: 121-6.10.1016/0304-3835(96)04242-5Search in Google Scholar

Friedrich B, Jung K, Lein M, Türk I, Rudolph B, Hampel G, et al. Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue. Eur J Cancer 1999; 35: 138-44.10.1016/S0959-8049(98)00273-1Search in Google Scholar

Schweiger A, Staib A, Werle B, Krasovec M, Lah TT, Ebert W, et al. Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking. Br J Cancer 2000; 82: 782-8.10.1054/bjoc.1999.0999237439810732746Search in Google Scholar

Ueno T, Linder S, Na CL, Rice WR, Johansson J, Weaver TE. Processing of pulmonary surfactant protein B by napsin and cathepsin H. J Biol Chem 2004; 279: 16178-84.10.1074/jbc.M31202920014766755Search in Google Scholar

Serveau-Avesque C, Martino MF, Hervé-Grépinet V, Hazouard E, Gauthier F, Diot E, et al. Active cathepsins B, H, K, L and S in human inflammatory bronchoalveolar lavage fluids. Biol Cell 2006; 98: 15-22.10.1042/BC2004051216354158Search in Google Scholar

Brasch F, Ten Brinke A, Johnen G, Ochs M, Kapp N, Müller KM, et al. Involvement of cathepsin H in the processing of the hydrophobic surfactantassociated protein C in type II pneumocytes. Am J Respir Cell Mol Biol 2002; 26: 659-70.10.1165/ajrcmb.26.6.474412034564Search in Google Scholar

D'Angelo ME, Bird PI, Peters C, Reinheckel T, Trapani JA, Sutton VR. Cathepsin H is an additional convertase of pro-granzyme B. J Biol Chem 2010; 285: 20514-9.10.1074/jbc.M109.094573289831320435891Search in Google Scholar

Lü J, Qian J, Keppler D, Cardoso WV. Cathespin H is an Fgf10 target involved in Bmp4 degradation during lung branching morphogenesis. J Biol Chem 2007; 282: 22176-84.10.1074/jbc.M70006320017500053Search in Google Scholar

Hogan BL. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 1996; 10: 1580-94.10.1101/gad.10.13.15808682290Search in Google Scholar

Deng H, Ravikumar TS, Yang WL. Overexpression of bone morphogenetic protein 4 enhances the invasiveness of Smad4-deficient human colorectal cancer cells. Cancer Lett 2009; 281: 220-31.10.1016/j.canlet.2009.02.046Search in Google Scholar

Maegdefrau U, Amann T, Winklmeier A, Braig S, Schubert T, Weiss TS, et al. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression. J Pathol 2009; 218: 520-9.10.1002/path.2563Search in Google Scholar

Cui Y, Jean F, Thomas G, Christian JL. BMP-4 is proteolytically activated by furin and/or PC6 during vertebrate embryonic development. EMBO J 1998; 17: 4735-43.10.1093/emboj/17.16.4735Search in Google Scholar

Degnin C, Jean F, Thomas G, Christian JL. Cleavages within the prodomain direct intracellular trafficking and degradation of mature bone morphogenetic protein-4. Mol Biol Cell 2004; 15: 5012-20.10.1091/mbc.e04-08-0673Search in Google Scholar

Goldman DC, Hackenmiller R, Nakayama T, Sopory S, Wong C, Kulessa H, et al. Mutation of an upstream cleavage site in the BMP4 prodomain leads to tissue-specific loss of activity. Development 2006; 133: 1933-42.10.1242/dev.02368Search in Google Scholar

Schweiger A, Stabuc B, Popovíc T, Turk V, Kos J. Enzyme-linked immunosorbent assay for the detection of total cathepsin H in human tissue cytosols and sera. J Immunol Methods 1997; 201: 165-72.10.1016/S0022-1759(96)00218-9Search in Google Scholar

Jevnikar Z, Obermajer N, Bogyo M, Kos J. The role of cathepsin X in the migration and invasiveness of T lymphocytes. J Cell Sci 2008; 121: 2652-61.10.1242/jcs.02372118664495Search in Google Scholar

Angliker H, Wikstrom P, Kirschke H, Shaw E. The inactivation of the cysteinyl exopeptidases cathepsin H and C by affinity-labelling reagents. Biochem J 1989; 262: 63-8.10.1042/bj262006311332292818577Search in Google Scholar

Obermajer N, Svajger U, Bogyo M, Jeras M, Kos J. Maturation of dendritic cells depends on proteolytic cleavage by cathepsin X. J Leukoc Biol 2008; 84: 1306-15.10.1189/jlb.0508285325284318701767Search in Google Scholar

Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004; 22: 233-41.10.1080/0897719041233127989015621726Search in Google Scholar

Kominami E, Tsukahara T, Bando Y, Katunuma N. Distribution of cathepsins B and H in rat tissues and peripheral blood cells. J Biochem 1985; 98: 87-93.10.1093/oxfordjournals.jbchem.a135277Search in Google Scholar

del Re EC, Shuja S, Cai J, Murnane MJ. Alterations in cathepsin H activity and protein patterns in human colorectal carcinomas. Br J Cancer 2000; 82: 1317-26.10.1054/bjoc.1999.1098Search in Google Scholar

Waghray A, Keppler D, Sloane BF, Schuger L, Chen YQ. Analysis of a truncated form of cathepsin H in human prostate tumor cells. J Biol Chem 2002; 277: 11533-8.10.1074/jbc.M109557200Search in Google Scholar

Cui Y, Hackenmiller R, Berg L, Jean F, Nakayama T, Thomas G, et al. The activity and signaling range of mature BMP-4 is regulated by sequential cleavage at two sites within the prodomain of the precursor. Genes Dev 2001; 15: 2797-802.10.1101/gad.940001Search in Google Scholar

Takahashi T, Dehdarani AH, Tang J. Porcine spleen cathepsin H hydrolyzes oligopeptides solely by aminopeptidase activity. J Biol Chem 1988; 263: 10952-7.10.1016/S0021-9258(18)38062-1Search in Google Scholar

Ohkawara B, Iemura S, ten Dijke P, Ueno N. Action range of BMP is defined by its N-terminal basic amino acid core. Curr Biol 2002; 12: 205-9.10.1016/S0960-9822(01)00684-4Search in Google Scholar

Zhou Z, Sun L, Wang Y, Wu Z, Geng J, Miu W, et al. Bone morphogenetic protein 4 inhibits cell proliferation and induces apoptosis in glioma stem cells. Cancer Biother Radiopharm 2011; 26: 77-83.10.1089/cbr.2010.085721355779Search in Google Scholar

Lombardo Y, Scopelliti A, Cammareri P, Todaro M, Iovino F, Ricci-Vitiani L, et al. Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. Gastroenterology 2011; 140: 297-309.10.1053/j.gastro.2010.10.00520951698Search in Google Scholar

Goldman DC, Bailey AS, Pfaffle DL, Al Masri A, Christian JL, Fleming WH. BMP4 regulates the hematopoietic stem cell niche. Blood 2009; 114: 4393-401.10.1182/blood-2009-02-206433277712419759357Search in Google Scholar

Ardebili SY, Zajc I, Gole B, Campos B, Herold-Mende C, Drmota S, Lah TT. CD133/prominin1 is prognostic for GBM patient's survival, but inversely correlated with cysteine cathepsins' expression in glioblastoma derived spheroids. Radiol Oncol 2011; 45: 102-15.10.2478/v10019-011-0015-6342373122933943Search in Google Scholar